Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Cash from Financing Activities (2022 - 2026)

GE HealthCare Technologies filings provide 5 years of Cash from Financing Activities readings, the most recent being $21.0 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 107.34% to $21.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $924.0 million, a 230.88% increase, with the full-year FY2025 number at $617.0 million, up 207.68% from a year prior.
  • Cash from Financing Activities hit $21.0 million in Q1 2026 for GE HealthCare Technologies, up from -$293.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $1.4 billion in Q2 2025 to a low of -$1.3 billion in Q4 2024.
  • Median Cash from Financing Activities over the past 5 years was -$153.0 million (2024), compared with a mean of -$72.6 million.
  • Biggest five-year swings in Cash from Financing Activities: tumbled 2332.43% in 2023 and later soared 3908.33% in 2024.
  • GE HealthCare Technologies' Cash from Financing Activities stood at -$37.0 million in 2022, then tumbled by 2332.43% to -$900.0 million in 2023, then tumbled by 41.89% to -$1.3 billion in 2024, then skyrocketed by 77.06% to -$293.0 million in 2025, then skyrocketed by 107.17% to $21.0 million in 2026.
  • The last three reported values for Cash from Financing Activities were $21.0 million (Q1 2026), -$293.0 million (Q4 2025), and -$165.0 million (Q3 2025) per Business Quant data.